Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 4;24(7):6742.
doi: 10.3390/ijms24076742.

Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization

Affiliations
Review

Unveiling the Differences in Signaling and Regulatory Mechanisms between Dopamine D2 and D3 Receptors and Their Impact on Behavioral Sensitization

Kyeong-Man Kim. Int J Mol Sci. .

Abstract

Dopamine receptors are classified into five subtypes, with D2R and D3R playing a crucial role in regulating mood, motivation, reward, and movement. Whereas D2R are distributed widely across the brain, including regions responsible for motor functions, D3R are primarily found in specific areas related to cognitive and emotional functions, such as the nucleus accumbens, limbic system, and prefrontal cortex. Despite their high sequence homology and similar signaling pathways, D2R and D3R have distinct regulatory properties involving desensitization, endocytosis, posttranslational modification, and interactions with other cellular components. In vivo, D3R is closely associated with behavioral sensitization, which leads to increased dopaminergic responses. Behavioral sensitization is believed to result from D3R desensitization, which removes the inhibitory effect of D3R on related behaviors. Whereas D2R maintains continuous signal transduction through agonist-induced receptor phosphorylation, arrestin recruitment, and endocytosis, which recycle and resensitize desensitized receptors, D3R rarely undergoes agonist-induced endocytosis and instead is desensitized after repeated agonist exposure. In addition, D3R undergoes more extensive posttranslational modifications, such as glycosylation and palmitoylation, which are needed for its desensitization. Overall, a series of biochemical settings more closely related to D3R could be linked to D3R-mediated behavioral sensitization.

Keywords: biased signaling; desensitization; dimerization; dopamine D2 and D3 receptor; intracellular trafficking; posttranslational modification; signal transduction.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Major posttranslational modification sites of dopamine D2 receptor and their functional roles. S/T residues highlighted in red indicate GRK-mediated phosphorylation sites; circles filled with yellow and S/T residues highlighted in purple indicate the amino acids responsible for GRK-mediated D2R endocytosis; S/T residues highlighted in blue indicate PKC-mediated phosphorylation sites.
Figure 2
Figure 2
Major posttranslational modification sites of dopamine D3 receptor and their functional roles. Circles filled with yellow indicate the amino acids responsible for agonist-induced desensitization; the two S residues highlighted in red indicate PKC-mediated regulatory processes.
Figure 3
Figure 3
Sequence alignment of dopamine D2 and D3 receptors. D2LR represents alternatively spliced long form of dopamine D2 receptor. The asparagine residues (N) indicated by orange letters located within the N-terminal tail or within the extracellular loops represent potential N-linked glycosylation sites. Asterisks indicate amino acid residues involved in biased signaling. For details, please refer to the text.

Similar articles

Cited by

References

    1. Lee T., Seeman P., Rajput A., Farley I.J., Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in Parkinson’s disease. Nature. 1978;273:59–61. doi: 10.1038/273059a0. - DOI - PubMed
    1. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse. 1987;1:133–152. doi: 10.1002/syn.890010203. - DOI - PubMed
    1. Cunnah D., Besser M. Management of prolactinomas. Clin. Endocrinol. 1991;34:231–235. doi: 10.1111/j.1365-2265.1991.tb00299.x. - DOI - PubMed
    1. Brown J.H., Makman M.H. Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adeno-sine-3′:5′-cyclic monophosphate formation in intact retina. Proc. Natl. Acad. Sci. USA. 1972;69:539–543. doi: 10.1073/pnas.69.3.539. - DOI - PMC - PubMed
    1. De Camilli P., Macconi D., Spada A. Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas. Nature. 1979;278:252–254. doi: 10.1038/278252a0. - DOI - PubMed

MeSH terms

LinkOut - more resources